Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70422 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Dawn Y Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Mycophenolic Acid, Immunosuppressive Agents, Graft Rejection. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Mycophenolic acid (MPA) is a common immunosuppressant used in children post‐orthotopic heart transplant (OHT). Multiple MPA dosing strategies exist, with limited reports of comparisons between dosing strategies and patient outcomes.
Methods
We performed a retrospective review of heart transplant recipients ≤ 21 years from 2014 to 2022, comparing dose concordance and clinical outcomes of weight‐based mycophenolate dosing (15 mg/kg/dose every 12 h) to body surface area (BSA)‐based dosing (600 mg/m 2 /dose every 12 h).
Results
We analyzed 109 patients total (56% in the BSA‐based cohort and 44% in the weight‐based cohort). The BSA‐based cohort received a higher total milligram dose (480 (IQR 200–563) vs. 636 (IQR 320–1000), p = 0.005), mg/kg dose (14.5 (IQR 13.7–16.1) vs. 20.7 (IQR 16.4–25.8), p < 0.001) and mg/m 2 dose (382 (IQR 333–470) vs. 596 (IQR 572–612), p < 0.001) compared to the weight‐based cohort. The BSA‐based cohort experienced a lower hazard of rejection (HR 0.2, 95% CI 0.1–0.4 vs. weight‐based) and a greater hazard for overall infection (HR 2.2, 95% CI 1.2–3.9). There was no significant difference in 1‐year post‐transplant mortality and incidence of post‐transplant lymphoproliferative disorder (PTLD).
Conclusions
This study demonstrates the discordance between two common mycophenolate dosing strategies (1200 mg/m 2 /day vs. 30 mg/kg/day) and its resultant impact on pediatric heart transplant‐related outcomes. Further multicenter data would be useful to elucidate the impact on post‐heart transplant morbidity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
ORCID-Profile: Dawn Y Nguyen, Anastacia Serluco, Justin K Chen, Gwen Nance, Zeling He, Arene Butto
Zitieren
APA
Nguyen, D. Y., Serluco, A., Chen, J. K., Nance, G., He, Z., & Butto, A. (2026). Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant. Clinical Transplantation. https://doi.org/10.1111/ctr.70422
Vancouver
Nguyen DY, Serluco A, Chen JK, Nance G, He Z, Butto A. Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant. Clinical Transplantation. 2026. doi:10.1111/ctr.70422
BibTeX
@article{Nguyen2026,
author = {Nguyen, Dawn Y and Serluco, Anastacia and Chen, Justin K and Nance, Gwen and He, Zeling and Butto, Arene},
title = {Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70422}
}
EUVIMED